Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
C4 Therapeutics, Inc
About CCCC
C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on delivering targeted protein degradation science to create a new generation of medicines that transform patients’ lives. The Company is focused on progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to design and optimize small-molecule medicines to address difficult-to-treat diseases. Its advanced product candidate, cemsidomide, is an orally bioavailable MonoDAC degrader of protein targets called IKZF1 and IKZF3. Cemsidomide is in clinical development for multiple myeloma (MM), and non-Hodgkin lymphoma (NHL). Its CFT1946 is an orally bioavailable BiDAC degrader designed to be potent and selective against BRAF V600X mutant proteins. It is also developing CFT8919, an orally bioavailable, allosteric, mutant-selective BiDAC degrader of epidermal growth factor receptor (EGFR), with an L858R mutation in non-small lung cancer (NSCLC).
Find out what a historical investment in C4 Therapeutics, Inc would be worth today using our CCCC stock calculator.
Market Capitalisation
$343.86M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.55M
High today
$3.39
Low today
$3.14
Open price
$3.16
52-week high
$3.95
52-week low
$1.21
Ready to start your investing journey with Stake?
Open an accountHow do I buy CCCC shares in Australia?
Buying CCCC shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in C4 Therapeutics, Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CCCC
What is the ticker symbol of C4 Therapeutics, Inc?
The ticker symbol for C4 Therapeutics, Inc is CCCC.
How much is one share of CCCC?
One share of CCCC is valued at $3.26 as of 20 May 2026.
What is the market capitalisation of C4 Therapeutics, Inc CCCC?
As of 20 May 2026 C4 Therapeutics, Inc has a market cap of $343.86M.
What is the 52-week high for C4 Therapeutics, Inc stock?
The C4 Therapeutics, Inc 52-week high stock price is $3.95.
What is the 52-week low for C4 Therapeutics, Inc stock?
The C4 Therapeutics, Inc 52-week low stock price is $1.21.
Can I buy CCCC shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CCCC shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CCCC on Stake
- Buy CCCC from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of CCCC from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
CCCC related stocks